Every material Form 8-K CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Creative Medical Technology Holdings' Compensation Committee approved bonuses of $100,000 for CEO Timothy Warbington and $25,000 for CFO Donald Dickerson on November 6, 2025, according to an 8-K filed November 12, 2025. The filing does not state the basis for the bonuses or any performance criteria, and it contains no financial results or changes in officer roles.
Compensation Committee approved the bonuses on November 6, 2025
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →